Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide in Pediatric Short Bowel Syndrome
NCT01952080Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2013
- Primary completion
- Jan 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started Nov 2013; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT01952080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01952080.